Equities researchers at Dougherty & Co lifted their price target on shares of Cardiovascular Systems (NASDAQ:CSII) from $21.00 to $28.00 in a research report issued on Monday, Analyst Ratings.Net reports. The firm currently has a “buy” rating on the stock. Dougherty & Co’s price objective would indicate a potential upside of 30.66% from the company’s current price.
Separately, analysts at Benchmark Co. cut their price target on shares of Cardiovascular Systems from $24.00 to $23.00 in a research note to investors on Thursday, May 2nd.
Shares of Cardiovascular Systems (NASDAQ: CSII) opened at 21.35 on Monday. Cardiovascular Systems has a one year low of $8.60 and a one year high of $22.67. The stock’s 50-day moving average is currently $21.41. The company’s market cap is $513.3 million.
Cardiovascular Systems, Inc (NASDAQ: CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.